DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma

Although alteration of DNA methylation in advanced cancer has been extensively investigated, few data for early-stage lung adenocarcinoma are available. Here, we compared DNA methylation profiles between adenocarcinoma in situ (AIS) and early invasive adenocarcinoma using the Infinium methylation ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Husni, Ryan Edbert, Shiba-Ishii, Aya, Nakagawa, Tomoki, Dai, Tomoko, Kim, Yunjung, Hong, Jeongmin, Sakashita, Shingo, Sakamoto, Noriaki, Sato, Yukio, Noguchi, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422190/
https://www.ncbi.nlm.nih.gov/pubmed/30899432
http://dx.doi.org/10.18632/oncotarget.26676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422190/
https://www.ncbi.nlm.nih.gov/pubmed/30899432
http://dx.doi.org/10.18632/oncotarget.26676

Ejemplares similares